IOL CHEMICALS & PHARM. | FABINO LIFE | IOL CHEMICALS & PHARM./ FABINO LIFE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | - | - | View Chart |
P/BV | x | 1.6 | 1.5 | 105.6% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. FABINO LIFE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
FABINO LIFE Mar-23 |
IOL CHEMICALS & PHARM./ FABINO LIFE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 38 | 1,414.2% | |
Low | Rs | 272 | 23 | 1,209.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 16.0 | 2,360.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.1 | 45,244.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.2 | 15,781.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 19.6 | 1,310.6% | |
Shares outstanding (eoy) | m | 58.71 | 2.10 | 2,795.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.9 | 56.7% | |
Avg P/E ratio | x | 17.1 | 590.4 | 2.9% | |
P/CF ratio (eoy) | x | 12.8 | 149.3 | 8.6% | |
Price / Book Value ratio | x | 1.6 | 1.5 | 102.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 63 | 37,407.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2 | 88,068.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 34 | 65,985.4% | |
Other income | Rs m | 256 | 0 | 116,409.1% | |
Total revenues | Rs m | 22,427 | 34 | 66,293.8% | |
Gross profit | Rs m | 2,257 | 0 | 644,771.4% | |
Depreciation | Rs m | 462 | 0 | 144,250.0% | |
Interest | Rs m | 165 | 0 | 126,692.3% | |
Profit before tax | Rs m | 1,887 | 0 | 1,572,083.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | 4,951,000.0% | |
Profit after tax | Rs m | 1,391 | 0 | 1,264,909.1% | |
Gross profit margin | % | 10.2 | 1.0 | 989.3% | |
Effective tax rate | % | 26.2 | 10.8 | 242.3% | |
Net profit margin | % | 6.3 | 0.3 | 1,952.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 48 | 20,256.7% | |
Current liabilities | Rs m | 5,025 | 4 | 112,925.8% | |
Net working cap to sales | % | 20.9 | 128.8 | 16.3% | |
Current ratio | x | 1.9 | 10.7 | 17.9% | |
Inventory Days | Days | 43 | 8 | 510.4% | |
Debtors Days | Days | 8 | 274,533,512 | 0.0% | |
Net fixed assets | Rs m | 11,017 | 2 | 485,348.0% | |
Share capital | Rs m | 587 | 21 | 2,795.7% | |
"Free" reserves | Rs m | 14,490 | 20 | 71,911.2% | |
Net worth | Rs m | 15,077 | 41 | 36,639.6% | |
Long term debt | Rs m | 0 | 4 | 0.0% | |
Total assets | Rs m | 20,684 | 50 | 41,376.1% | |
Interest coverage | x | 12.5 | 1.9 | 647.6% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 159.5% | |
Return on assets | % | 7.5 | 0.5 | 1,563.8% | |
Return on equity | % | 9.2 | 0.3 | 3,516.2% | |
Return on capital | % | 13.6 | 0.6 | 2,426.3% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -7 | -18,114.1% | |
From Investments | Rs m | -1,200 | NA | 1,090,909.1% | |
From Financial Activity | Rs m | -41 | 3 | -1,208.8% | |
Net Cashflow | Rs m | -18 | -3 | 531.8% |
Indian Promoters | % | 48.2 | 56.8 | 84.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 43.2 | 120.0% | |
Shareholders | 130,003 | 138 | 94,205.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | FABINO LIFE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.84% | -4.99% | -0.21% |
1-Month | 6.42% | -22.58% | -0.30% |
1-Year | -1.58% | -10.43% | 53.46% |
3-Year CAGR | -12.79% | -10.31% | 14.83% |
5-Year CAGR | 17.57% | -6.32% | 19.74% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the FABINO LIFE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of FABINO LIFE the stake stands at 56.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of FABINO LIFE .
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
FABINO LIFE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of FABINO LIFE .
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.